Robotic nerve-sparing radical hysterectomy for locally advanced cervical cancer after neo-adjuvant chemotherapy

Experts Meeting on Gynecologic Oncology

May 19-21, 2016 San Antonio, USA

Yuanqing Yao

PLA General Hospital, China

Posters & Accepted Abstracts: J Cancer Sci Ther

Abstract :

Objective: To evaluate the feasibility and safety of robotic nerve-sparing radical hysterectomy for Locally Advanced Cervical Cancer (LACC). Methods: In a retrospective study, data were analyzed for patients treated for cervical cancer at a center in Beijing, China, between December 2011 and September 2013. Patients were subdivided into those with early-stage disease (FIGO stage IA2� IB1) who were treated by robotic surgery (group 1), and those with LACC (stage IB2�IIB) who were treated by robotic surgery after neo-adjuvant chemotherapy (NACT). Therapeutic outcomes and complications were compared. Results: Group 1 included 32 patients and group 2 included 22 patients. Two patients in group 2 did not respond to NACT and did not undergo surgery. The operative outcomes and incidences of complications did not differ significantly between the two groups (p>0.05 for all). There were no differences in nodal yield, lengths of parametrium removed, or vaginal cuff length (p>0.05 for all). During a mean follow-up of 26 months, no patient experienced recurrence. Conclusion: Robotic nerve-sparing radical hysterectomy was found to be feasible and safe for LACC after NACT. A larger case series with longer follow-up data is needed to justify its widespread application.

Biography :

Email: yqyao301hp@163.com